September 15, 2026-September 16, 2026 Register Now: C-Path’s 2026 Global Impact Conference C-Path's flagship event is set to return to downtown Washington, D.C. this September 15-16 at the...
August 24, 2026 Building a Stronger Path to Therapies for Hereditary Spastic Paraplegia and Primary Lateral Sclerosis For more than 20 years, the Spastic Paraplegia Foundation (SPF) has worked toward a future with better treatments
August 20, 2026 C-Path Achieves Internationally Recognized Certification for Information Security Management C-Path) today announced it has achieved certification to ISO/IEC 27001:2022, the internationally...
August 20, 2026 Mapping First Steps Scaling Genetic Medicines: C-Path’s Romero Joins BioCentury Podcast Critical Path Institute’s One to Millions Initiative is using individualized rare disease therapies...
August 18, 2026 C-Path Receives FDA Qualification for Rheumatoid Arthritis Fatigue Measure TUCSON, Ariz., August 18, 2026 — Critical Path Institute’s® (C-Path) Patient-Centered Evidence Consortium today announced...
August 17, 2026 Amplifying the Voices Behind the Science: Celebrating National Nonprofit Day with Our Partners Every day, nonprofit organizations work on the most stubborn problems in global health.
August 6, 2026 C-Path’s Duchenne Consortium Awarded a $1.9 Million DoD Grant to Advance Understanding of Cardiomyopathy in Duchenne Muscular Dystrophy TUCSON, Ariz. August 6, 2026 — Critical Path Institute® (C-Path) today announced it has been awarded a grant in the amount...
July 31, 2026 The Critical Path Institute Podcast: How C-Path’s Accelerator Is Impacting Tomorrow’s Medicines This episode of the Critical Path Institute podcast features Maaike Everts, Executive Director of C-Path’s Translational The
July 29, 2026 eCOA Consortium and PCE Consortium Webinar Recording: Event Driven eDiaries At C-Path’s 2026 Clinical Outcome Assessment Program Annual Meeting, attendees heard a brief overview of...
July 29, 2026 Scaling the Science: The Maturation of NAMs and the Demand for Validated Scaling The commercial and regulatory reality of New Approach Methodologies (NAMs) materialized rapidly this conference season.